These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 14622555

  • 1. [Coronary risk in Spain and its treatment with lipid-lowering drugs].
    Maiques Galán A, Villar Alvarez F, Llor Vila C, Torcal Laguna J.
    Aten Primaria; 2003 Oct 31; 32(7):420-2. PubMed ID: 14622555
    [No Abstract] [Full Text] [Related]

  • 2. Lipid-lowering drug therapy: more knowledge leads to more problems for composers of guidelines.
    Durrington PN, Illingworth DR.
    Curr Opin Lipidol; 2000 Aug 31; 11(4):345-9. PubMed ID: 10945714
    [No Abstract] [Full Text] [Related]

  • 3. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb 13; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Primary and secondary prevention using lipid-lowering therapies.
    Holm K.
    J Cardiovasc Nurs; 2000 Jan 13; 14(2):1-8. PubMed ID: 10653271
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland.
    Strandberg TE, Vanhanen H, Tikkanen MJ.
    Am J Cardiol; 1999 Jul 01; 84(1):95, A8. PubMed ID: 10404860
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of hyperlipidaemia as a risk factor for coronary heart disease: the role of fibrates.
    Linssen R.
    Hosp Med; 1999 Apr 01; 60(4):298-301. PubMed ID: 10396439
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A case for lipid-lowering?
    Durrington P.
    Diabet Med; 2000 Sep 01; 17 Suppl 2():4-5. PubMed ID: 11048824
    [No Abstract] [Full Text] [Related]

  • 14. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ, Marín Ibáñez A, Pérez-Jiménez F, Pintó X, Nocea G, Ahumada C, Alemao E, Yin D, REALITY Study Group.
    Pharmacoeconomics; 2004 Sep 01; 22 Suppl 3():1-12. PubMed ID: 15669149
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Implications of 4S evidence on baseline lipid levels.
    Jacobson TA.
    Lancet; 1995 Jul 15; 346(8968):181-2. PubMed ID: 7603245
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ineffectiveness of lipid-lowering therapy in primary care.
    Van Ganse E, Souchet T, Laforest L, Moulin P, Bertrand M, Le Jeunne P, Travier N, Yin D, Alemao E, de Pouvourville G.
    Br J Clin Pharmacol; 2005 Apr 15; 59(4):456-63. PubMed ID: 15801941
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.